ULTRAVIST® (iopromide) Injection

All nonionic, iodinated contrast media currently available inhibit blood coagulation in vitro less than ionic contrast media. Clotting has been reported when blood remains in contact with syringes containing nonionic contrast media. Therefore, meticulous intravascular administration technique is necessary to minimize thromboembolic events. As with all iodinated contrast agents, serious or fatal reactions have been associated with their use.

ULTRAVIST injection is not indicated for intrathecal use.

You need to have the Adobe^® Acrobat Reader installed on your computer to view some of the documents on this site.

You can download a copy of the Adobe^® Acrobat Reader by clicking the icon below.